JUN ZHONG: Open Payments
NPI 1427448893 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 34 payments from 9 companies in 2025. Trend: 2023 $29 · 2024 $311 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $145 |
| Janssen Pharmaceuticals, Inc | 7 | $138 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| Lundbeck LLC | 3 | $81 |
| Almatica Pharma LLC | 3 | $61 |
| Indivior Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| Brainsway USA INC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: REXULTI, VRAYLAR, SPRAVATO, LOREEV XR, SUBLOCADE, ZEPBOUND, Deep TMS System, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
